Risks to the 340B Drug Pricing Program—Reply
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2022-09, Vol.328 (11), p.1109-1110 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1110 |
---|---|
container_issue | 11 |
container_start_page | 1109 |
container_title | JAMA : the journal of the American Medical Association |
container_volume | 328 |
creator | Knox, Ryan P Sarpatwari, Ameet |
description | |
doi_str_mv | 10.1001/jama.2022.12756 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2716090141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2796384</ama_id><sourcerecordid>2716090141</sourcerecordid><originalsourceid>FETCH-LOGICAL-a177t-b79ea0552d4da62d614c4757d24b51662ea341e56cbd3ac22c930189e6f891523</originalsourceid><addsrcrecordid>eNo1kL1OwzAUhS0EEqUwIzFlZEnqe_0_QvmVKoEqmC3XcUtK0hQ7HbrxEDwhT0JD4S5HuvrOGT5CzoEWQCmMlq5xBVLEAlAJeUAGIJjOmTD6kAwoNTpXXPNjcpLSku4OmBqQYlql95R1bda9hYxxep3dxM0ie46Vr1Z9tovomu_Pr2lY19tTcjR3dQpnfzkkr3e3L-OHfPJ0_zi-muQOlOrymTLBUSGw5KWTWErgniuhSuQzAVJicIxDENLPSuY8ojeMgjZBzrUBgWxILve769h-bELqbFMlH-rarUK7SRYVSGoocNihoz3qY5tSDHO7jlXj4tYCtb0Z25uxvRn7a2bXuNg3-v8_jMpIpjn7AX_ZXWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2716090141</pqid></control><display><type>article</type><title>Risks to the 340B Drug Pricing Program—Reply</title><source>American Medical Association Journals</source><creator>Knox, Ryan P ; Sarpatwari, Ameet</creator><creatorcontrib>Knox, Ryan P ; Sarpatwari, Ameet</creatorcontrib><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.2022.12756</identifier><language>eng</language><publisher>American Medical Association</publisher><ispartof>JAMA : the journal of the American Medical Association, 2022-09, Vol.328 (11), p.1109-1110</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a177t-b79ea0552d4da62d614c4757d24b51662ea341e56cbd3ac22c930189e6f891523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.2022.12756$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.12756$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,315,781,785,3341,27929,27930,76494,76497</link.rule.ids></links><search><creatorcontrib>Knox, Ryan P</creatorcontrib><creatorcontrib>Sarpatwari, Ameet</creatorcontrib><title>Risks to the 340B Drug Pricing Program—Reply</title><title>JAMA : the journal of the American Medical Association</title><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo1kL1OwzAUhS0EEqUwIzFlZEnqe_0_QvmVKoEqmC3XcUtK0hQ7HbrxEDwhT0JD4S5HuvrOGT5CzoEWQCmMlq5xBVLEAlAJeUAGIJjOmTD6kAwoNTpXXPNjcpLSku4OmBqQYlql95R1bda9hYxxep3dxM0ie46Vr1Z9tovomu_Pr2lY19tTcjR3dQpnfzkkr3e3L-OHfPJ0_zi-muQOlOrymTLBUSGw5KWTWErgniuhSuQzAVJicIxDENLPSuY8ojeMgjZBzrUBgWxILve769h-bELqbFMlH-rarUK7SRYVSGoocNihoz3qY5tSDHO7jlXj4tYCtb0Z25uxvRn7a2bXuNg3-v8_jMpIpjn7AX_ZXWQ</recordid><startdate>20220920</startdate><enddate>20220920</enddate><creator>Knox, Ryan P</creator><creator>Sarpatwari, Ameet</creator><general>American Medical Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220920</creationdate><title>Risks to the 340B Drug Pricing Program—Reply</title><author>Knox, Ryan P ; Sarpatwari, Ameet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a177t-b79ea0552d4da62d614c4757d24b51662ea341e56cbd3ac22c930189e6f891523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Knox, Ryan P</creatorcontrib><creatorcontrib>Sarpatwari, Ameet</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Knox, Ryan P</au><au>Sarpatwari, Ameet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risks to the 340B Drug Pricing Program—Reply</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><date>2022-09-20</date><risdate>2022</risdate><volume>328</volume><issue>11</issue><spage>1109</spage><epage>1110</epage><pages>1109-1110</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><pub>American Medical Association</pub><doi>10.1001/jama.2022.12756</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0098-7484 |
ispartof | JAMA : the journal of the American Medical Association, 2022-09, Vol.328 (11), p.1109-1110 |
issn | 0098-7484 1538-3598 |
language | eng |
recordid | cdi_proquest_miscellaneous_2716090141 |
source | American Medical Association Journals |
title | Risks to the 340B Drug Pricing Program—Reply |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T20%3A57%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risks%20to%20the%20340B%20Drug%20Pricing%20Program%E2%80%94Reply&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Knox,%20Ryan%20P&rft.date=2022-09-20&rft.volume=328&rft.issue=11&rft.spage=1109&rft.epage=1110&rft.pages=1109-1110&rft.issn=0098-7484&rft.eissn=1538-3598&rft_id=info:doi/10.1001/jama.2022.12756&rft_dat=%3Cproquest_cross%3E2716090141%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2716090141&rft_id=info:pmid/&rft_ama_id=2796384&rfr_iscdi=true |